Managing sharp, intense pain immediately following surgery is a major challenge for both patients and doctors. While morphine is a common choice, it often comes with heavy side effects that can make recovery uncomfortable. Researchers looked at tegileridine as a possible alternative to see how it stacks up against placebo and morphine.
In a review of data from over 1,000 patients, tegileridine proved much more effective than a placebo at reducing pain scores. When compared directly to morphine, tegileridine performed similarly in some measures but was significantly weaker than morphine in others. This suggests it works well for pain relief, even if it is not as potent as morphine.
One of the biggest wins for tegileridine is its safety profile. While it had more side effects than a placebo, those issues were similar to morphine's levels. However, patients taking tegileridine experienced much less nausea and vomiting than those taking morphine. These findings suggest tegileridine could be a useful option for managing post-surgery pain while keeping patients more comfortable.
